{"entity":{"type":"insider","cik":"0001913245","url":"/insider/0001913245","json_url":"/insider/0001913245.json","name":"Danahy Kevin Patrick","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":7,"first":"2022-10-03","last":"2026-02-23","span_basis":"filed_date"},"name_variants":[{"name":"Danahy Kevin Patrick","source":"filing","n_filings":7,"first_seen":"2022-10-03","last_seen":"2026-02-23"}],"transactions":[{"id":6210722,"accession":"0001437749-26-005144","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-26-005144","line_url":"/filing/0001437749-26-005144#line-2","is_derivative":false,"issuer_cik":"0001625101","issuer_name":"PULSE BIOSCIENCES, INC.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001625101","owner_cik":"0001913245","owner_name":"Danahy Kevin Patrick","owner_display_name":"Danahy Kevin Patrick","owner_url":"/insider/0001913245","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":23.64,"price_display":"23.64","price_state":"stated","total_value":118200.0,"total_display":"118,200.00","total_whole":"118,200","shares_owned_after":43298.0,"shares_owned_after_display":"43,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-18","filed_date":"2026-02-23","scope":"insider"},{"id":6053293,"accession":"0001437749-26-004438","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001437749-26-004438","line_url":"/filing/0001437749-26-004438#line-6","is_derivative":false,"issuer_cik":"0001625101","issuer_name":"PULSE BIOSCIENCES, INC.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001625101","owner_cik":"0001913245","owner_name":"Danahy Kevin Patrick","owner_display_name":"Danahy Kevin Patrick","owner_url":"/insider/0001913245","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":23.63,"price_display":"23.63","price_state":"stated","total_value":472600.0,"total_display":"472,600.00","total_whole":"472,600","shares_owned_after":43298.0,"shares_owned_after_display":"43,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-17","filed_date":"2026-02-17","scope":"insider"},{"id":6053288,"accession":"0001437749-26-004438","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001437749-26-004438","line_url":"/filing/0001437749-26-004438#line-4","is_derivative":false,"issuer_cik":"0001625101","issuer_name":"PULSE BIOSCIENCES, INC.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001625101","owner_cik":"0001913245","owner_name":"Danahy Kevin Patrick","owner_display_name":"Danahy Kevin Patrick","owner_url":"/insider/0001913245","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":23.53,"price_display":"23.53","price_state":"stated","total_value":470600.0,"total_display":"470,600.00","total_whole":"470,600","shares_owned_after":43298.0,"shares_owned_after_display":"43,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-13","filed_date":"2026-02-17","scope":"insider"},{"id":6053283,"accession":"0001437749-26-004438","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-26-004438","line_url":"/filing/0001437749-26-004438#line-2","is_derivative":false,"issuer_cik":"0001625101","issuer_name":"PULSE BIOSCIENCES, INC.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001625101","owner_cik":"0001913245","owner_name":"Danahy Kevin Patrick","owner_display_name":"Danahy Kevin Patrick","owner_url":"/insider/0001913245","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":23.37,"price_display":"23.37","price_state":"stated","total_value":467400.0,"total_display":"467,400.00","total_whole":"467,400","shares_owned_after":43298.0,"shares_owned_after_display":"43,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-12","filed_date":"2026-02-17","scope":"insider"},{"id":5777280,"accession":"0001437749-26-003840","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001437749-26-003840","line_url":"/filing/0001437749-26-003840#line-6","is_derivative":false,"issuer_cik":"0001625101","issuer_name":"PULSE BIOSCIENCES, INC.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001625101","owner_cik":"0001913245","owner_name":"Danahy Kevin Patrick","owner_display_name":"Danahy Kevin Patrick","owner_url":"/insider/0001913245","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":25.2,"price_display":"25.20","price_state":"stated","total_value":504000.0,"total_display":"504,000.00","total_whole":"504,000","shares_owned_after":43298.0,"shares_owned_after_display":"43,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-11","filed_date":"2026-02-11","scope":"insider"},{"id":5777278,"accession":"0001437749-26-003840","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001437749-26-003840","line_url":"/filing/0001437749-26-003840#line-4","is_derivative":false,"issuer_cik":"0001625101","issuer_name":"PULSE BIOSCIENCES, INC.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001625101","owner_cik":"0001913245","owner_name":"Danahy Kevin Patrick","owner_display_name":"Danahy Kevin Patrick","owner_url":"/insider/0001913245","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":23.52,"price_display":"23.52","price_state":"stated","total_value":470400.0,"total_display":"470,400.00","total_whole":"470,400","shares_owned_after":43298.0,"shares_owned_after_display":"43,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-10","filed_date":"2026-02-11","scope":"insider"},{"id":5777276,"accession":"0001437749-26-003840","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-26-003840","line_url":"/filing/0001437749-26-003840#line-2","is_derivative":false,"issuer_cik":"0001625101","issuer_name":"PULSE BIOSCIENCES, INC.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001625101","owner_cik":"0001913245","owner_name":"Danahy Kevin Patrick","owner_display_name":"Danahy Kevin Patrick","owner_url":"/insider/0001913245","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":21.45,"price_display":"21.45","price_state":"stated","total_value":429000.0,"total_display":"429,000.00","total_whole":"429,000","shares_owned_after":43298.0,"shares_owned_after_display":"43,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-09","filed_date":"2026-02-11","scope":"insider"},{"id":4217199,"accession":"0001437749-25-030665","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-25-030665","line_url":"/filing/0001437749-25-030665#line-2","is_derivative":false,"issuer_cik":"0001625101","issuer_name":"PULSE BIOSCIENCES, INC.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001625101","owner_cik":"0001913245","owner_name":"Danahy Kevin Patrick","owner_display_name":"Danahy Kevin Patrick","owner_url":"/insider/0001913245","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4600.0,"shares_display":"4,600","price_per_share":18.53,"price_display":"18.53","price_state":"stated","total_value":85238.0,"total_display":"85,238.00","total_whole":"85,238","shares_owned_after":43298.0,"shares_owned_after_display":"43,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-07","scope":"insider"},{"id":4040234,"accession":"0001437749-25-029646","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001437749-25-029646","line_url":"/filing/0001437749-25-029646#line-4","is_derivative":false,"issuer_cik":"0001625101","issuer_name":"PULSE BIOSCIENCES, INC.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001625101","owner_cik":"0001913245","owner_name":"Danahy Kevin Patrick","owner_display_name":"Danahy Kevin Patrick","owner_url":"/insider/0001913245","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":18.48,"price_display":"18.48","price_state":"stated","total_value":7392.0,"total_display":"7,392.00","total_whole":"7,392","shares_owned_after":43298.0,"shares_owned_after_display":"43,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-19","filed_date":"2025-09-22","scope":"insider"},{"id":4040230,"accession":"0001437749-25-029646","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-25-029646","line_url":"/filing/0001437749-25-029646#line-2","is_derivative":false,"issuer_cik":"0001625101","issuer_name":"PULSE BIOSCIENCES, INC.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001625101","owner_cik":"0001913245","owner_name":"Danahy Kevin Patrick","owner_display_name":"Danahy Kevin Patrick","owner_url":"/insider/0001913245","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":18.49,"price_display":"18.49","price_state":"stated","total_value":369800.0,"total_display":"369,800.00","total_whole":"369,800","shares_owned_after":43298.0,"shares_owned_after_display":"43,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-18","filed_date":"2025-09-22","scope":"insider"},{"id":8495945,"accession":"0001437749-23-032410","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001437749-23-032410","line_url":"/filing/0001437749-23-032410","is_derivative":false,"issuer_cik":"0001625101","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001625101","owner_cik":"0001913245","owner_name":"Danahy Kevin Patrick","owner_display_name":"Danahy Kevin Patrick","owner_url":"/insider/0001913245","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5393.0,"shares_display":"5,393","price_per_share":6.51875429260152,"price_display":"6.52","price_state":"stated","total_value":35155.6419,"total_display":"35,155.64","total_whole":"35,156","shares_owned_after":35275.0,"shares_owned_after_display":"35,275","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-16","filed_date":"2023-11-17","scope":"insider","n_lines":3},{"id":6336267,"accession":"0001839882-22-022698","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001839882-22-022698","line_url":"/filing/0001839882-22-022698#line-1","is_derivative":false,"issuer_cik":"0001625101","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001625101","owner_cik":"0001913245","owner_name":"Danahy Kevin Patrick","owner_display_name":"Danahy Kevin Patrick","owner_url":"/insider/0001913245","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6500.0,"shares_display":"6,500","price_per_share":2.3,"price_display":"2.30","price_state":"stated","total_value":14950.0,"total_display":"14,950.00","total_whole":"14,950","shares_owned_after":6500.0,"shares_owned_after_display":"6,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-30","filed_date":"2022-10-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001625101","name":"PULSE BIOSCIENCES, INC.","url":"/issuer/0001625101","role":"Officer (Chief Commercial Officer)","n_filings":7,"first_seen":"2022-10-03","last_seen":"2026-02-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001913245","retrieved_at":"2026-08-23T11:21:41+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}